Demographic and clinical characteristics of allogeneic BMT survivors and siblings
Variable . | BMT survivors, n = 1554 . | Siblings, n = 907 . | P . |
---|---|---|---|
VTE, n (%) | |||
Yes | 80 (5.15) | 29 (3.20) | .023 |
Age at survey, y | |||
Mean (SD) | 50.51 (15.38) | 54.17 (14.65) | <.0001 |
Sex, n (%) | |||
Male | 830 (53.41) | 361 (39.80) | <.0001 |
Race/Ethnicity, n (%) | <.0001 | ||
White | 1137 (73.17) | 783 (86.33) | |
Hispanic | 236 (15.19) | 66 (7.28) | |
Asian | 30 (1.93) | 19 (2.09) | |
Black | 104 (6.69) | 29 (3.20) | |
Other | 47 (3.02) | 10 (1.10) | |
Education, n (%) | .0005 | ||
≤High school | 264 (16.99) | 117 (12.90) | |
Some college | 565 (36.36) | 310 (34.18) | |
College graduate | 679 (43.69) | 473 (52.15) | |
Missing | 46 (2.96) | 7 (0.77) | |
Household income, n (%) | <.0001 | ||
≤$50000 | 458 (29.47) | 198 (21.83) | |
$50000-$100000 | 435 (27.99) | 268 (29.55) | |
>$100000 | 633 (40.73) | 347 (38.26) | |
Missing | 28 (1.80) | 94 (10.36) | |
History of smoking, n (%) | |||
Ever | 478 (30.76) | 353 (38.92) | <.0001 |
Alcohol intake, n (%) | |||
Yes | 768 (48.42) | 540 (59.54) | <.0001 |
Exercise, n (%) | |||
Yes | 1106 (71.17) | 725 (79.93) | <.0001 |
Comorbidities, n (%) | |||
Diabetes | 228 (15.33) | 38 (4.33) | <.0001 |
Hypertension | 448 (33.09) | 187 (22.48) | <.0001 |
Dyslipidemia | 411 (30.22) | 155 (18.59) | <.0001 |
Chronic kidney disease | 58 (3.77) | 33 (3.65) | .877 |
Congestive heart failure | 65 (4.20) | 13 (1.44) | .0002 |
Coronary heart disease | 52 (3.35) | 26 (2.87) | .507 |
Arrhythmia | 143 (9.43) | 59 (6.58) | .014 |
Stroke | 50 (3.22) | 14 (1.55) | .012 |
Chronic GVHD | 506 (34.47) | Not applicable | Not applicable |
Medications, n (%) | |||
Oral contraceptive use | 446 (28.70) | 407 (44.87) | <.0001 |
Female hormone replacement | 532 (34.23) | 105 (11.58) | <.0001 |
Testosterone replacement | 235 (15.12) | 40 (4.41) | <.0001 |
Immunosuppressants | 959 (61.71) | 44 (4.85) | <.0001 |
Variable . | BMT survivors, n = 1554 . | Siblings, n = 907 . | P . |
---|---|---|---|
VTE, n (%) | |||
Yes | 80 (5.15) | 29 (3.20) | .023 |
Age at survey, y | |||
Mean (SD) | 50.51 (15.38) | 54.17 (14.65) | <.0001 |
Sex, n (%) | |||
Male | 830 (53.41) | 361 (39.80) | <.0001 |
Race/Ethnicity, n (%) | <.0001 | ||
White | 1137 (73.17) | 783 (86.33) | |
Hispanic | 236 (15.19) | 66 (7.28) | |
Asian | 30 (1.93) | 19 (2.09) | |
Black | 104 (6.69) | 29 (3.20) | |
Other | 47 (3.02) | 10 (1.10) | |
Education, n (%) | .0005 | ||
≤High school | 264 (16.99) | 117 (12.90) | |
Some college | 565 (36.36) | 310 (34.18) | |
College graduate | 679 (43.69) | 473 (52.15) | |
Missing | 46 (2.96) | 7 (0.77) | |
Household income, n (%) | <.0001 | ||
≤$50000 | 458 (29.47) | 198 (21.83) | |
$50000-$100000 | 435 (27.99) | 268 (29.55) | |
>$100000 | 633 (40.73) | 347 (38.26) | |
Missing | 28 (1.80) | 94 (10.36) | |
History of smoking, n (%) | |||
Ever | 478 (30.76) | 353 (38.92) | <.0001 |
Alcohol intake, n (%) | |||
Yes | 768 (48.42) | 540 (59.54) | <.0001 |
Exercise, n (%) | |||
Yes | 1106 (71.17) | 725 (79.93) | <.0001 |
Comorbidities, n (%) | |||
Diabetes | 228 (15.33) | 38 (4.33) | <.0001 |
Hypertension | 448 (33.09) | 187 (22.48) | <.0001 |
Dyslipidemia | 411 (30.22) | 155 (18.59) | <.0001 |
Chronic kidney disease | 58 (3.77) | 33 (3.65) | .877 |
Congestive heart failure | 65 (4.20) | 13 (1.44) | .0002 |
Coronary heart disease | 52 (3.35) | 26 (2.87) | .507 |
Arrhythmia | 143 (9.43) | 59 (6.58) | .014 |
Stroke | 50 (3.22) | 14 (1.55) | .012 |
Chronic GVHD | 506 (34.47) | Not applicable | Not applicable |
Medications, n (%) | |||
Oral contraceptive use | 446 (28.70) | 407 (44.87) | <.0001 |
Female hormone replacement | 532 (34.23) | 105 (11.58) | <.0001 |
Testosterone replacement | 235 (15.12) | 40 (4.41) | <.0001 |
Immunosuppressants | 959 (61.71) | 44 (4.85) | <.0001 |